| Product Code: ETC10689324 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sri Lanka Oncology Companion Diagnostics Market Overview |
3.1 Sri Lanka Country Macro Economic Indicators |
3.2 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Sri Lanka Oncology Companion Diagnostics Market - Industry Life Cycle |
3.4 Sri Lanka Oncology Companion Diagnostics Market - Porter's Five Forces |
3.5 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
4 Sri Lanka Oncology Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer cases in Sri Lanka |
4.2.2 Growing awareness about personalized medicine and targeted therapies |
4.2.3 Technological advancements in oncology companion diagnostics |
4.3 Market Restraints |
4.3.1 Lack of skilled healthcare professionals in the field of oncology diagnostics |
4.3.2 High cost associated with companion diagnostics testing |
4.3.3 Limited access to advanced diagnostic technologies in certain regions of Sri Lanka |
5 Sri Lanka Oncology Companion Diagnostics Market Trends |
6 Sri Lanka Oncology Companion Diagnostics Market, By Types |
6.1 Sri Lanka Oncology Companion Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Technology, 2021 - 2031F |
6.1.3 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By NGS-Based, 2021 - 2031F |
6.1.5 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By IHC-Based, 2021 - 2031F |
6.1.6 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By FISH-Based, 2021 - 2031F |
6.2 Sri Lanka Oncology Companion Diagnostics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.5 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Ovarian Cancer, 2021 - 2031F |
6.3 Sri Lanka Oncology Companion Diagnostics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.3.4 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Diagnostic Labs, 2021 - 2031F |
6.3.5 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 Sri Lanka Oncology Companion Diagnostics Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Sri Lanka Oncology Companion Diagnostics Market Revenues & Volume, By Urine, 2021 - 2031F |
7 Sri Lanka Oncology Companion Diagnostics Market Import-Export Trade Statistics |
7.1 Sri Lanka Oncology Companion Diagnostics Market Export to Major Countries |
7.2 Sri Lanka Oncology Companion Diagnostics Market Imports from Major Countries |
8 Sri Lanka Oncology Companion Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of oncology companion diagnostics by healthcare providers |
8.2 Number of research and development collaborations for innovative diagnostic solutions |
8.3 Patient outcomes and survival rates post companion diagnostics testing |
8.4 Rate of reimbursement approvals for companion diagnostics testing |
8.5 Investments in infrastructure for oncology diagnostics facilities |
9 Sri Lanka Oncology Companion Diagnostics Market - Opportunity Assessment |
9.1 Sri Lanka Oncology Companion Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Sri Lanka Oncology Companion Diagnostics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Sri Lanka Oncology Companion Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Sri Lanka Oncology Companion Diagnostics Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
10 Sri Lanka Oncology Companion Diagnostics Market - Competitive Landscape |
10.1 Sri Lanka Oncology Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Sri Lanka Oncology Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here